Consensus DSM-Firmenich

Equities

DSFIR

CH1216478797

Consumer Goods Conglomerates

End-of-day quote Euronext Amsterdam Other stock markets 2026-01-16			5-day change	1st Jan Change
66.60 ^CHF	-2.46%		-1.77%	-3.14%

01-14	DSM-Firmenich AG Announces Executive and Committee Changes	CI
01-14	DSM-Firmenich Names New Chief Human Resources Officer	MT

Evolution of the Average Target: DSM-Firmenich

Evolution of the Target Price: DSM-Firmenich

Changes in Analyst Recommendations: DSM-Firmenich

990.IlSqFVWAjs2MjZhxsOVAXCng57IKKAa14Oofp5DdixA.SmDSZxTno5zZ-dIS0bUPMkOvtMdSYUT0l7lNn_qn6ldbI_J-JbS7gb_D9w~904ed45378b1d67d700c33eb1f58aeb2

Analysts' recommendations: DSM-Firmenich

12-30	Berenberg Reduces DSM-Firmenich PT, Keeps Buy Rating	MT
12-30	Berenberg Expects DSM-Firmenich to Retain Minority Stake in Vitamins Business Amid 'Protracted' Deal Talks	MT
11-13	Barclays Downgrades DSM-Firmenich to Equalweight, Cuts PT	MT
11-11	Goldman Sachs Downgrades DSM-Firmenich to Neutral, Cuts PT	MT
25-10-30	DSM-FIRMENICH : From energy to fatigue: DSM-Firmenich's soft Q3
25-10-22	AlphaValue/Baader Europe Revises DSM-Firmenich's Price Target Amid 'More Conservative' Outlook	MT
25-10-20	DSM-FIRMENICH : Adopting a more conservative outlook in updated forecast assumptions
25-09-24	Deutsche Bank Cuts DSM-Firmenich PT, Keeps Buy Rating	MT
25-07-31	DSM-FIRMENICH : H1 25 results in line, boosted by temporary vitamin price tailwind
25-07-15	AlphaValue/Baader Europe Upgrades DSM-Firmenich to Buy, Lifts PT	MT
25-05-02	DSM-FIRMENICH : Temporary vitamin effect lasts longer
25-04-04	DSM-FIRMENICH : Focus on ESG brings a better future
25-03-26	DSM-FIRMENICH : Fixing what others have done
25-02-17	DSM-FIRMENICH : The temporary vitamin effect may last for longer.
25-02-13	DSM-FIRMENICH : Taking Q4 momentum into Q1 2025
25-01-10	BNP Paribas Exane Upgrades DSM-Firmenich to Outperform, Raises PT	MT
25-01-09	Stifel Upgrades DSM-Firmenich to Buy, Lifts PT	MT
24-11-03	DSM-FIRMENICH : Vitamin shortage plays into the management's hands
24-08-30	Kepler Cheuvreux Upgrades DSM-Firmenich to Buy, Boosts PT	MT
24-08-13	DSM-FIRMENICH : Vitamins strong final chord
24-08-05	DSM-FIRMENICH : EPS upgrade (2024: +10.0%, 2025: +2.4%)
24-07-30	DSM-FIRMENICH : Guidance lifted after a strong Q2
24-05-02	DSM-FIRMENICH : Vitamin trouble is going to fade
24-04-05	DSM-FIRMENICH : A stronger long-term outlook
24-02-16	DSM-FIRMENICH : Some mess from the combination

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	DSM-FIRMENICH					+48.86%
	BERKSHIRE HATHAWAY INC.					+3.74%
	HITACHI, LTD.					+7.63%
	HONEYWELL INTERNATIONAL INC.					+7.58%
	MITSUBISHI HEAVY INDUSTRIES, LTD.					+2.05%
	3M COMPANY					+4.83%
	ILLINOIS TOOL WORKS INC.					-0.52%
	MITSUBISHI ELECTRIC CORPORATION					-15.82%
	JARDINE MATHESON HOLDINGS LIMITED					+3.65%
	Average					+6.89%
	Weighted average by Cap.					+3.92%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

66.60EUR

Average target price

99.14EUR

Spread / Average Target

+48.86%

High Price Target

125.00EUR

Spread / Highest target

+87.69%

Low Price Target

70.00EUR

Spread / Lowest Target

+5.11%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Berenberg Bank
Barclays
Goldman Sachs
alphavalue	Filippo Ercole Piva
Deutsche Bank Research
AlphaValue/Baader Europe
BNP Paribas
Stifel Nicolaus
Kepler Cheuvreux